Rodríguez A, Borrás J M, López-Torrecilla J, Algara M, Palacios-Eito A, Gómez-Caamaño A, Olay L, Lara P C
Department of Radiation Oncology, Hospital Ruber Internacional, C/La Masó 38, 28034, Madrid, Spain.
Universidad de Barcelona, IDIBELL, Gran Vía de L'Hospitalet 199, Hospitalet del Llobregat, 08908, Barcelona, Spain.
Clin Transl Oncol. 2017 Feb;19(2):204-210. doi: 10.1007/s12094-016-1525-x. Epub 2016 Aug 4.
Assessing the demand for radiotherapy in Spain based on existing evidence to estimate the human resources and equipment needed so that every person in Spain has access to high-quality radiotherapy when they need it.
We used data from the European Cancer Observatory on the estimated incidence of cancer in Spain in 2012, along with the evidence-based indications for radiotherapy developed by the Australian CCORE project, to obtain an optimal radiotherapy utilisation proportion (OUP) for each tumour.
About 50.5 % of new cancers in Spain require radiotherapy at least once over the course of the disease. Additional demand for these services comes from reradiation therapy and non-melanoma skin cancer. Approximately, 25-30 % of cancer patients with an indication for radiotherapy do not receive it due to factors that include access, patient preference, familiarity with the treatment among physicians, and especially resource shortages, all of which contribute to its underutilisation.
Radiotherapy is underused in Spain. The increasing incidence of cancer expected over the next decade and the greater frequency of reradiations necessitate the incorporation of radiotherapy demand into need-based calculations for cancer services planning.
基于现有证据评估西班牙对放射治疗的需求，以估计所需的人力资源和设备，从而使西班牙的每个人在需要时都能获得高质量的放射治疗。
我们使用了欧洲癌症观测站关于2012年西班牙癌症估计发病率的数据，以及澳大利亚CCORE项目制定的基于证据的放射治疗指征，以获得每种肿瘤的最佳放射治疗利用率（OUP）。
西班牙约50.5%的新发癌症在疾病过程中至少需要接受一次放射治疗。这些服务的额外需求来自再放射治疗和非黑色素瘤皮肤癌。大约25%-30%有放射治疗指征的癌症患者由于包括可及性、患者偏好、医生对治疗的熟悉程度，尤其是资源短缺等因素而未接受治疗，所有这些因素都导致了放射治疗的利用不足。
放射治疗在西班牙未得到充分利用。预计未来十年癌症发病率将上升，再放射治疗的频率也会增加，因此有必要将放射治疗需求纳入基于需求的癌症服务规划计算中。
